Hepion Pharmaceuticals
HEPA
#10558
Rank
HK$6.24 M
Marketcap
HK$0.54
Share price
7.81%
Change (1 day)
-99.72%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2025 (TTM): -HK$36.88 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.13 Billion, an increase over its 2023 earnings that were of -HK$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$36.88 Million-69.57%
2024 -HK$0.13 Billion-68.5%
2023 -HK$0.39 Billion9.74%
2022 -HK$0.36 Billion37.49%
2021 -HK$0.26 Billion61.27%
2020 -HK$0.16 Billion174.55%
2019 -HK$57.61 Million-31.28%
2018 -HK$83.84 Million
2016 -HK$0.17 Billion6.03%
2015 -HK$0.16 Billion265%
2014 -HK$42.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$1.16 Billion 3,034.96%๐Ÿ‡บ๐Ÿ‡ธ USA